Literature DB >> 23160193

Mutant huntingtin impairs immune cell migration in Huntington disease.

Wanda Kwan1, Ulrike Träger, Dimitrios Davalos, Austin Chou, Jill Bouchard, Ralph Andre, Aaron Miller, Andreas Weiss, Flaviano Giorgini, Christine Cheah, Thomas Möller, Nephi Stella, Katerina Akassoglou, Sarah J Tabrizi, Paul J Muchowski.   

Abstract

In Huntington disease (HD), immune cells are activated before symptoms arise; however, it is unclear how the expression of mutant huntingtin (htt) compromises the normal functions of immune cells. Here we report that primary microglia from early postnatal HD mice were profoundly impaired in their migration to chemotactic stimuli, and expression of a mutant htt fragment in microglial cell lines was sufficient to reproduce these deficits. Microglia expressing mutant htt had a retarded response to a laser-induced brain injury in vivo. Leukocyte recruitment was defective upon induction of peritonitis in HD mice at early disease stages and was normalized upon genetic deletion of mutant htt in immune cells. Migration was also strongly impaired in peripheral immune cells from pre-manifest human HD patients. Defective actin remodeling in immune cells expressing mutant htt likely contributed to their migration deficit. Our results suggest that these functional changes may contribute to immune dysfunction and neurodegeneration in HD, and may have implications for other polyglutamine expansion diseases in which mutant proteins are ubiquitously expressed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160193      PMCID: PMC3533551          DOI: 10.1172/JCI64484

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  74 in total

1.  Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats.

Authors:  V Chaparro-Huerta; M C Rivera-Cervantes; M E Flores-Soto; U Gómez-Pinedo; C Beas-Zárate
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

2.  Activated immune system in patients with Huntington's disease.

Authors:  F Leblhuber; J Walli; K Jellinger; G P Tilz; B Widner; F Laccone; D Fuchs
Journal:  Clin Chem Lab Med       Date:  1998-10       Impact factor: 3.694

3.  Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.

Authors:  Daniel Zwilling; Shao-Yi Huang; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Paolo Guidetti; Hui-Qiu Wu; Jason Lee; Jennifer Truong; Yaisa Andrews-Zwilling; Eric W Hsieh; Jamie Y Louie; Tiffany Wu; Kimberly Scearce-Levie; Christina Patrick; Anthony Adame; Flaviano Giorgini; Saliha Moussaoui; Grit Laue; Arash Rassoulpour; Gunnar Flik; Yadong Huang; Joseph M Muchowski; Eliezer Masliah; Robert Schwarcz; Paul J Muchowski
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

4.  Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy.

Authors:  R Lodi; A H Schapira; D Manners; P Styles; N W Wood; D J Taylor; T T Warner
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

5.  Lentiviral transduction of microglial cells.

Authors:  Stephanie Balcaitis; Jonathan R Weinstein; Sheng Li; Jeffrey S Chamberlain; Thomas Möller
Journal:  Glia       Date:  2005-04-01       Impact factor: 7.452

6.  Microglia density decreases with age in a mouse model of Huntington's disease.

Authors:  Li Ma; A Jennifer Morton; Louise F B Nicholson
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

7.  Chromosomal profiles of gene expression in Huntington's disease.

Authors:  Alexander N Anderson; Federico Roncaroli; Angela Hodges; Manuel Deprez; Federico E Turkheimer
Journal:  Brain       Date:  2007-12-21       Impact factor: 13.501

8.  Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.

Authors:  Wanda Kwan; Anna Magnusson; Austin Chou; Anthony Adame; Monica J Carson; Shinichi Kohsaka; Eliezer Masliah; Thomas Möller; Richard Ransohoff; Sarah J Tabrizi; Maria Björkqvist; Paul J Muchowski
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

9.  Deficiency of huntingtin has pleiotropic effects in the social amoeba Dictyostelium discoideum.

Authors:  Michael A Myre; Amanda L Lumsden; Morgan N Thompson; Wilma Wasco; Marcy E MacDonald; James F Gusella
Journal:  PLoS Genet       Date:  2011-04-28       Impact factor: 5.917

Review 10.  The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.

Authors:  Michael P Blundell; Austen Worth; Gerben Bouma; Adrian J Thrasher
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

View more
  61 in total

Review 1.  iPSC-based drug screening for Huntington's disease.

Authors:  Ningzhe Zhang; Barbara J Bailus; Karen L Ring; Lisa M Ellerby
Journal:  Brain Res       Date:  2015-09-30       Impact factor: 3.252

2.  Cofilin Mediates LPS-Induced Microglial Cell Activation and Associated Neurotoxicity Through Activation of NF-κB and JAK-STAT Pathway.

Authors:  Qasim Alhadidi; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2017-02-13       Impact factor: 5.590

Review 3.  The choreography of neuroinflammation in Huntington's disease.

Authors:  Andrea Crotti; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-05-20       Impact factor: 16.687

Review 4.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

5.  αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.

Authors:  Ana Osório Oliveira; Alexander Osmand; Tiago Fleming Outeiro; Paul Joseph Muchowski; Steven Finkbeiner
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

Review 6.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

7.  Caveolin isoform switching as a molecular, structural, and metabolic regulator of microglia.

Authors:  Ingrid R Niesman; Nathan Zemke; Heidi N Fridolfsson; Kristofer J Haushalter; Karen Levy; Anna Grove; Rosalie Schnoor; J Cameron Finley; Piyush M Patel; David M Roth; Brian P Head; Hemal H Patel
Journal:  Mol Cell Neurosci       Date:  2013-07-10       Impact factor: 4.314

Review 8.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

9.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

Review 10.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.